Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Joffre

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue De L'Infirmiere|June 17, 2018
[The hyperbaric chamber, a hostile working environment]Thierry Joffre, Nathalie Tomasso, Alexandre Guy, et al.
Revue De L'Infirmiere|June 17, 2018
[Hypnoanalgesia, a complementary therapy for painful care procedures]Jean-Guy Martinez, Marie-Pierre Delaunay, Nathalie Tomasso, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost AloneMarie-Anne Magnan, Angèle Gayet-Ageron, Pierre Louge, et al.
BMJ Open|November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue De L'Infirmiere|June 17, 2018
[The hyperbaric chamber, a hostile working environment]Thierry Joffre, Nathalie Tomasso, Alexandre Guy, et al.
Revue De L'Infirmiere|June 17, 2018
[Hypnoanalgesia, a complementary therapy for painful care procedures]Jean-Guy Martinez, Marie-Pierre Delaunay, Nathalie Tomasso, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost AloneMarie-Anne Magnan, Angèle Gayet-Ageron, Pierre Louge, et al.
BMJ Open|November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
Pageof 1